On December 28, the National Medical Insurance Administration announced the results of the 2020 drug negotiations and the adjustment of the medical insurance drug catalog.
According to Xiong Xianjun, Director of the Medical Service Management Department of the National Medical Insurance Administration, a total of 119 drugs have been successfully negotiated in 2020, and the average price of these drugs will be reduced by 50.64%.
In this adjustment, drugs related to the treatment of new coronary pneumonia such as ribavirin injection and arbidol particles have been transferred to the catalog. The drugs listed in the latest version of the national new coronary pneumonia diagnosis and treatment plan have all been included in the national medical insurance catalog.
(Reporter Shan Lu, Wen Mengxin, editor Zhou Jing)
Editor in charge: 【Luo Pan】